P. John Byrnes's most recent trade in Avanos Medical Inc was a trade of 8,378 Common Stock done . Disclosure was reported to the exchange on Jan. 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | P. John Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 8,378 | 49,618 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 7,008 | 41,240 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,354 | 34,232 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,005 | 28,878 (0%) | 0% | 0 | Common Stock |